Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer
Paige C. Arneson‐Wissink, Alexandra Q. Bartlett, Heike Mendez, Xinxia Zhu, Peter R. Levasseur, Parham Diba, Namratha Turuvekere Vittala Murthy, Jessica Dickie, Matthew McWhorter, Antony Jozić, Yulia Eygeris, Gaurav Sahay, Katelyn T. Byrne, Gregory David Scott, Robert L Eil, Aaron J. Grossberg
This study shows that IL-6 enhances T cell-mediated anti-tumor immunity in pancreatic cancer by increasing lymphoid aggregates, CD4 T cells, and reducing Tregs.
Cellular and Molecular Gastroenterology and Hepatology · Jan 1, 2026Peer-reviewedCancer Biology